Ultramicrosize Griseofulvin
NDC 0115-1725, Ultramicrosize Griseofulvin Tablets, tablet, coated, from Amneal Pharmaceuticals of New York LLC.
- Product NDC
- 0115-1725
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA204371
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0115-1725 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GRISEOFULVIN250 mg/1
Pharmacologic classes
Decreased Mitosis [PE]; Microtubule Inhibition [PE]; Tubulin Inhibiting Agent [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0115-1725-01 | 00115172501 | 100 TABLET, COATED in 1 BOTTLE, PLASTIC (0115-1725-01) |
| 0115-1725-03 | 00115172503 | 1000 TABLET, COATED in 1 BOTTLE, PLASTIC (0115-1725-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f21314eb-3581-4e06-9fe7-8239cc80ba11NADAC price for package 00115172501
GET /v1/drugs/nadac/00115172501
Use it
Look up 0115-1725 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0115-1725 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0115-1725. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.